GSA Capital Partners LLP Makes New Investment in Senseonics Holdings, Inc. (NYSE:SENS)

GSA Capital Partners LLP acquired a new stake in Senseonics Holdings, Inc. (NYSE:SENS) in the third quarter, HoldingsChannel reports. The institutional investor acquired 334,092 shares of the company’s stock, valued at approximately $117,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in SENS. State Board of Administration of Florida Retirement System bought a new position in shares of Senseonics during the 1st quarter worth approximately $91,000. Virtu Financial LLC acquired a new position in Senseonics during the first quarter worth $162,000. Price T Rowe Associates Inc. MD lifted its holdings in shares of Senseonics by 16.1% during the first quarter. Price T Rowe Associates Inc. MD now owns 367,200 shares of the company’s stock valued at $196,000 after acquiring an additional 51,000 shares during the period. Cubist Systematic Strategies LLC boosted its stake in shares of Senseonics by 25.9% in the 2nd quarter. Cubist Systematic Strategies LLC now owns 415,404 shares of the company’s stock valued at $166,000 after purchasing an additional 85,501 shares in the last quarter. Finally, Symmetry Partners LLC acquired a new stake in shares of Senseonics in the 3rd quarter valued at $164,000. 12.36% of the stock is owned by institutional investors.

Senseonics Trading Down 3.9 %

Shares of SENS opened at $0.30 on Tuesday. The company has a debt-to-equity ratio of 59.17, a quick ratio of 2.38 and a current ratio of 2.47. The company has a market cap of $180.86 million, a price-to-earnings ratio of -2.43 and a beta of 0.79. The stock has a fifty day moving average price of $0.34 and a two-hundred day moving average price of $0.39. Senseonics Holdings, Inc. has a 52-week low of $0.28 and a 52-week high of $0.75.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently issued reports on the stock. HC Wainwright reiterated a “buy” rating and set a $2.00 target price on shares of Senseonics in a research report on Friday, November 15th. StockNews.com initiated coverage on shares of Senseonics in a report on Sunday. They set a “sell” rating for the company.

Senseonics Company Profile

Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.